Information technology, improved access and use of prescription drugs
| dc.contributor.author | Böckerman Petri | |
| dc.contributor.author | Kortelainen Mika | |
| dc.contributor.author | Laine Liisa | |
| dc.contributor.author | Nurminen Mikko | |
| dc.contributor.author | Saxell Tanja | |
| dc.contributor.organization | fi=taloustiede|en=Economics| | |
| dc.contributor.organization-code | 1.2.246.10.2458963.20.17691981389 | |
| dc.converis.publication-id | 386951194 | |
| dc.converis.url | https://research.utu.fi/converis/portal/Publication/386951194 | |
| dc.date.accessioned | 2025-08-27T23:44:41Z | |
| dc.date.available | 2025-08-27T23:44:41Z | |
| dc.description.abstract | <p> We estimate the effects of health information technology designed to improve access to medication while limiting overuse through easier prescription renewal and improved information provision. We focus on benzodiazepines, a commonly prescribed class of mental health and insomnia medications, which are highly effective but potentially addictive. We study the staggered rollout of a nationwide electronic prescribing system over four years in Finland and use population-wide, individual-level administrative data sets. We find that e-prescribing increases average benzodiazepine use due to increased prescription renewals. The increase is most pronounced for younger patients. E-prescribing can improve the health of elderly patients and may help to balance the access-overuse trade-off. Without additional monitoring for addiction in place, it may, however, also have unintended health consequences for younger patients, who are more likely to develop mental and behavioral health disorders. <br></p> | |
| dc.format.pagerange | 396 | |
| dc.format.pagerange | 430 | |
| dc.identifier.eissn | 1542-4774 | |
| dc.identifier.jour-issn | 1542-4766 | |
| dc.identifier.olddbid | 204527 | |
| dc.identifier.oldhandle | 10024/187554 | |
| dc.identifier.uri | https://www.utupub.fi/handle/11111/53017 | |
| dc.identifier.url | https://doi.org/10.1093/jeea/jvae034 | |
| dc.identifier.urn | URN:NBN:fi-fe2025082786470 | |
| dc.language.iso | en | |
| dc.okm.affiliatedauthor | Kortelainen, Mika | |
| dc.okm.discipline | 511 Economics | en_GB |
| dc.okm.discipline | 511 Kansantaloustiede | fi_FI |
| dc.okm.internationalcopublication | international co-publication | |
| dc.okm.internationality | International publication | |
| dc.okm.type | A1 ScientificArticle | |
| dc.publisher | Oxford University Press | |
| dc.publisher.country | United Kingdom | en_GB |
| dc.publisher.country | Britannia | fi_FI |
| dc.publisher.country-code | GB | |
| dc.relation.doi | 10.1093/jeea/jvae034 | |
| dc.relation.ispartofjournal | Journal of the European Economic Association | |
| dc.relation.issue | 1 | |
| dc.relation.volume | 23 | |
| dc.source.identifier | https://www.utupub.fi/handle/10024/187554 | |
| dc.title | Information technology, improved access and use of prescription drugs | |
| dc.year.issued | 2024 |
Tiedostot
1 - 1 / 1